TRiCOPHARMiNGWe continue working in our research to collaborate with a treatment for the COVID-19. Watch the CMM Castilla-La Mancha Media interview about our work with Artemisia annua and its possible application in the fight against the virus.
read moreOur company Tricopharming was included by the ABC newspaper in the top of the biotechnology and ICT companies that are committed to development and innovation in Spain thanks to our biotechnology based on biopharmaceutical agriculture and our first success case Artennua®, a optimized version of Artemisia annua.
read moreGlad to announce that Tricopharming has been selected among the 20 most innovative tech startups of Catalonia Region within the framework of the Startup Capital 2019 call! Startup Capital boosts early stage technological companies helping to accelerate their product development and road map to market by co-financing business plan implementation. The call is addressed…
read moreLuis Matías, through his company Biotech Tricopharming Research, wants to study the antiviral properties of his product derived from Artemisia annua with the new coronavirus
read more
English
Español